n,n-dimethylarginine has been researched along with Uremia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jerman, A; Osredkar, J; Pajek, J; Pajek, M; Ponikvar, JB | 1 |
| Arefin, S; Carrero, JJ; Hammarqvist, F; Kublickiene, K; Näslund, E; Nordfors, L; Qureshi, AR; Rydén, M; Stenvinkel, P; Witasp, A | 1 |
| Dhondt, A; Eloot, S; Glorieux, G; Liabeuf, S; Massy, Z; Neirynck, N; Rroji, M; Van Biesen, W; Vandennoortgate, N; Vanholder, R | 1 |
| Prostran, M; Radenkovic, M; Stojanovic, M | 1 |
| Getino, MA; Jarque, A; Lozano, L; Mora-Fernández, C; Navarro, JF; Sánchez, R | 1 |
| Mallamaci, F; Zoccali, C | 1 |
| Chang, L; Chen, B; Xie, J; Zhang, W; Zhou, C | 1 |
| Azqueta, M; Cases, A; Coll, E; Collado, S; Cruzado, JM; de la Torre, B; Deulofeu, R; Guerrero, L; Nicolau, C; Pons, M; Vera, M | 1 |
| Asai, T; Blackwell, S; Dhaun, N; Goddard, J; Liebman, B; Lilitkarntakul, P; Melville, V; Pollock, J; Talwar, DK; Webb, DJ | 1 |
| Hörl, WH | 1 |
| Cohen, JJ; Harrington, JT; Hörl, WH; Madias, NE; Zusman, CJ | 1 |
| Kielstein, JT; Zoccali, C | 1 |
| Axelsson, J; Carrero, JJ; Heimbürger, O; Lindholm, B; Massy, Z; Stenvinkel, P | 1 |
| Arese, M; Bosia, A; Bussolino, F; Costamagna, C; Ghigo, D; MacAllister, R; Ruva, C; Strasly, M; Tetta, C; Verzetti, G | 1 |
| Ellory, JC; Lane, C; Mendes Ribeiro, AC; Roberts, NB; Yaqoob, M | 1 |
| Hoffmann, KH; MacAllister, RJ; Rambausek, MH; Ritz, E; Vallance, P; Williams, D | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Haller, H; Kielstein, JT | 1 |
6 review(s) available for n,n-dimethylarginine and Uremia
| Article | Year |
|---|---|
Endothelial Dysfunction in Renal Failure: Current Update.
Topics: Arginine; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress; Renal Insufficiency; Uremia; Vascular Cell Adhesion Molecule-1; Vitamin D Deficiency | 2016 |
[Novelties in the field of progression factors in chronic kidney disease].
Topics: Adult; Amidohydrolases; Animals; Arginine; Carbon; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Low Birth Weight; Infant, Newborn; Kidney Diseases; Male; Oxides; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Uremia; Uric Acid | 2008 |
[Atherosclerosis and uremia: signifance of non-traditional risk factors].
Topics: Arginine; Arteriosclerosis; Homocysteine; Humans; Kidney Failure, Chronic; Oxidative Stress; Phosphates; Prognosis; Risk Factors; Uremia | 2003 |
Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Endocrine System Diseases; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Rats; Rats, Inbred Dahl; Renal Dialysis; Risk Factors; Sodium Chloride, Dietary; Tunica Intima; Tunica Media; Uremia | 2005 |
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Topics: Albuminuria; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Ossification, Heterotopic; Oxidative Stress; Risk Assessment; Uremia | 2008 |
Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.
Topics: Arginine; Arteriosclerosis; Biomarkers; Humans; In Vitro Techniques; Kidney Failure, Chronic; Nitric Oxide; Peritoneal Dialysis; Renal Dialysis; Uremia | 2001 |
1 trial(s) available for n,n-dimethylarginine and Uremia
| Article | Year |
|---|---|
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.
Topics: Adult; Aged; Arginine; Chromatography, High Pressure Liquid; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Uremia | 1996 |
10 other study(ies) available for n,n-dimethylarginine and Uremia
| Article | Year |
|---|---|
Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients.
Topics: Adult; Aged; Arginine; beta 2-Microglobulin; Biomarkers; C-Reactive Protein; Female; Hand Strength; Humans; Indican; Inflammation; Insulin-Like Growth Factor I; Interleukin-6; Male; Middle Aged; Myostatin; Physical Functional Performance; Renal Dialysis; Toxins, Biological; Urea; Uremia; Walking | 2018 |
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Endothelium; Female; Gene Expression; Humans; Kidney; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; RNA, Messenger; Serum Amyloid P-Component; Subcutaneous Fat, Abdominal; Uremia; Vascular Resistance | 2013 |
Association of advanced age with concentrations of uraemic toxins in CKD.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Arginine; beta 2-Microglobulin; Biomarkers; Blood Urea Nitrogen; Creatinine; Female; Furans; Humans; Male; Middle Aged; Multivariate Analysis; Propionates; Renal Dialysis; Renal Insufficiency, Chronic; Uremia | 2016 |
Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Arteries; Humans; Kidney Diseases; Kidney Failure, Chronic; Risk Factors; Uremia | 2009 |
Serum asymmetric dimethylarginine and endothelial function after renal transplantation.
Topics: Adult; Arginine; Case-Control Studies; Endothelium, Vascular; Female; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Period; Uremia | 2009 |
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Proteins; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyperhomocysteinemia; Hyperlipidemias; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Risk Factors; Smoking; Stroke Volume; Ultrasonography; Uremia | 2010 |
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Case-Control Studies; Chronic Disease; Comorbidity; Compliance; Cross-Sectional Studies; Disease Progression; Endothelin-1; Endothelium, Vascular; Female; Femoral Artery; Glomerular Filtration Rate; Humans; Isoprostanes; Kidney; Kidney Diseases; Linear Models; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Pulsatile Flow; Risk Assessment; Risk Factors; Scotland; Uremia; Vasodilation | 2011 |
Atherosclerosis and uremic retention solutes.
Topics: Arginine; Arteriosclerosis; Female; Glomerulosclerosis, Focal Segmental; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Middle Aged; Nitric Oxide; Oxidative Stress; Phosphates; Uremia | 2004 |
Regulation of nitric oxide synthesis in uraemia.
Topics: Analysis of Variance; Animals; Arginine; Chronic Disease; Dialysis Solutions; Endothelium, Vascular; Female; Humans; Male; Mice; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Renal Dialysis; Uremia | 1995 |
Accumulation of the endogenous L-arginine analogue NG-monomethyl-L-arginine in human end-stage renal failure patients on regular haemodialysis.
Topics: Adult; Arginine; Biological Transport; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Erythrocytes; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Renal Dialysis; Scintillation Counting; Uremia | 1996 |